Iovance Biotherapeutics (IOVA) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Join SI Premium – FREE
(Updated - May 9, 2023 5:06 PM EDT)
Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
